Last Updated: June 25, 2026

Suppliers and packagers for IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aurobindo Pharma IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE ibuprofen; pseudoephedrine hydrochloride CAPSULE;ORAL 209235 ANDA WALGREEN CO. 0363-1106-08 4 BLISTER PACK in 1 CARTON (0363-1106-08) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK 2017-12-01
Aurobindo Pharma IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE ibuprofen; pseudoephedrine hydrochloride CAPSULE;ORAL 209235 ANDA WALGREEN CO. 0363-1106-67 2 BLISTER PACK in 1 CARTON (0363-1106-67) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK 2017-12-01
Aurobindo Pharma IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE ibuprofen; pseudoephedrine hydrochloride CAPSULE;ORAL 209235 ANDA Amerisource Bergen 46122-609-58 4 BLISTER PACK in 1 CARTON (46122-609-58) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK 2017-12-01
Aurobindo Pharma IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE ibuprofen; pseudoephedrine hydrochloride CAPSULE;ORAL 209235 ANDA Aurohealth LLC 58602-803-03 1 BLISTER PACK in 1 CARTON (58602-803-03) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (58602-803-83) 2017-12-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE

Last updated: April 25, 2026

Who Supplies Ibuprofen and Pseudoephedrine Hydrochloride?

What is the supply landscape for ibuprofen API and excipient-grade material?

Ibuprofen is a commodity API with broad upstream capacity. Global supply typically splits into:

  • API manufacturers (ibuprofen active pharmaceutical ingredient)
  • Chemical suppliers (ibuprofen intermediate or bulk-grade material that may be upgraded for pharma use)
  • Specialty ingredient suppliers (ibuprofen for formulation, relabeling, or regional sourcing)

Common supplier types by geography

  • China and India dominate ibuprofen API manufacturing and export flows.
  • Europe and US typically rely on imports for bulk ibuprofen API, with some regional capability for formulation and packaging.

Practical sourcing pattern Most buyers source ibuprofen through:

  • Direct API manufacturers supplying DMF/CEP-enabled documentation, or
  • Distributor/labeler networks that provide regional inventory, COAs, and established QA agreements.

What is the supply landscape for pseudoephedrine hydrochloride API?

Pseudoephedrine hydrochloride (PSE HCl) is a tightly controlled API due to its link to illicit drug production. Supply concentrates among:

  • Licensed chemical/API manufacturers
  • Contract manufacturers with controlled supply chains
  • Authorized distributors with compliance infrastructure

Practical sourcing pattern Pseudoephedrine is typically procured via:

  • Direct licensed sourcing where the buyer’s regulatory posture and end-use documentation are pre-cleared, or
  • Regional authorized distributors that manage quota, licensing, and recordkeeping.

Regulatory constraints that shape supply

  • Higher scrutiny on customer qualification
  • Quotas/permits
  • Stricter controls on logistics, documentation, and audit trails

Who are the known supplier categories in each segment?

Because pseudoephedrine supply is license-based, “supplier identity” is often verified by:

  • Regulatory listing status in the buyer’s jurisdiction
  • Controlled substance handling licenses
  • Ability to provide full compliance documentation (end-use, registrations, chain-of-custody)

For ibuprofen, identification is more straightforward because it is not typically handled with the same level of trafficking-control complexity.


What supplier archetypes exist in procurement?

Drug component Typical supplier archetype What buyers usually require
Ibuprofen API manufacturer or pharma-grade chemical supplier DMF/CEP where available, GMP COA, impurity profile, stability package
Pseudoephedrine HCl Licensed API manufacturer and authorized distributor Import/export licenses, quota/permits, end-use declarations, chain-of-custody controls

How to map suppliers to what you actually buy

Ibuprofen: what you should expect from supplier portfolios

Ibuprofen suppliers usually provide:

  • GMP API in standard pack sizes (typical bulk and IBC formats)
  • Quality documentation suitable for dossier support (COA, specification, impurity list)
  • Consistency of polymorph/impurity control depending on route and grade

If you are sourcing for tablets/capsules:

  • Buyers often standardize on a single API supplier to reduce variability across lots.
  • Many buyers dual-source to manage lead time and price volatility.

Pseudoephedrine HCl: what you should expect from supplier portfolios

Pseudoephedrine suppliers usually provide:

  • GMP API under controlled distribution arrangements
  • Compliance documentation tied to:
    • Buyer registration
    • End-use
    • Shipment tracking
    • Recordkeeping

A pseudoephedrine procurement model often requires:

  • Pre-approved suppliers and pre-cleared buyers
  • Limited alternate sources due to licensing and quota constraints

Key Takeaways

  • Ibuprofen is a commodity API with many qualified manufacturers and distribution routes.
  • Pseudoephedrine hydrochloride is a controlled API; supply is concentrated among licensed manufacturers and authorized distributors with compliance-first processes.
  • Procurement for pseudoephedrine is dominated by regulatory authorization, quota, and chain-of-custody, not just GMP and price.
  • Dual-sourcing is common for ibuprofen; for pseudoephedrine, sourcing flexibility is more constrained by licensing.

FAQs

  1. Is ibuprofen generally easier to source than pseudoephedrine HCl?
    Yes. Ibuprofen is broadly available as a commodity API, while pseudoephedrine HCl is controlled and requires licensing and quota-based distribution.

  2. Do pseudoephedrine suppliers require end-use documentation?
    Yes. Pseudoephedrine procurement is typically tied to end-use declarations and regulatory registrations.

  3. Can distributors supply both ibuprofen and pseudoephedrine HCl?
    Distributors commonly supply ibuprofen. Pseudoephedrine distributors must be authorized to handle controlled API logistics and recordkeeping.

  4. Do buyers usually qualify multiple suppliers for pseudoephedrine HCl?
    They may, but the practical number of qualified sources is often limited by licensing, quota allocation, and compliance capacity.

  5. What documentation matters most for these APIs?
    For ibuprofen: GMP COAs, specifications, and impurity profiles. For pseudoephedrine HCl: GMP documentation plus controlled-substance compliance records (licenses, end-use, chain-of-custody).


References

[1] U.S. Drug Enforcement Administration (DEA). Chemical Handler and Supplier Requirements (Controlled Chemical Provisions for Precursor Chemicals).
[2] European Medicines Agency (EMA). Guidelines and documentation expectations for GMP pharmaceutical substances and active ingredients.
[3] World Health Organization (WHO). Good Manufacturing Practices (GMP) guidance for pharmaceutical products and substances.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.